Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats

被引:10
|
作者
Chen, Kaizhen [1 ]
Teo, Shiyi [1 ]
Seng, Kok -Yong [1 ]
机构
[1] DSO Natl Labs, Def Med & Environm Res Inst, Bioengn Lab, Singapore 117510, Singapore
关键词
Acetylcholinesterase; allometric scaling; diisopropylfluorophosphate; physiologically-based pharmacokinetic and pharmacodynamic model; sensitivity analysis; RISK-ASSESSMENT; INHIBITION; ACETYLCHOLINESTERASE; PLASMA; SOMAN; EXPOSURE; FORMS;
D O I
10.1080/15376510903300335
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A physiologically-based pharmacokinetic and pharmacodynamic (PBPK/PD) model was recently developed to study the effect of diisopropylfluorophosphate (DFP) on acetylcholinesterase (AChE) activity in mouse and rat. That model takes into account relatively complex interactions involving many parameters, some of which may be uncertain and/or highly variable, especially those characterizing AChE activity after DFP intoxication. The primary objective of this study was to identify parameters that contribute most to the variability of AChE dynamics for model optimization against data. For this purpose, the influence of the variability of the rate constants for synthesis (K-syn) and degradation (K-deg) of AChE, and regeneration (K-reg) and aging (K-age) of inhibited AChE on the variability of AChE activity in mice and rat venous blood and brain was first calculated by a global sensitivity analysis. Next, the mouse PBPK/PD model was calibrated by optimizing the values of K-syn, K-deg, K-reg and K-age. Thereafter, scale-up of the DFP-induced AChE activity was performed from mouse to rat. Validation of the rat model was performed by comparing the time course of venous blood and brain AChE activities from a Monte Carlo analysis to those obtained in vivo. Sensitivity analysis on the verified models showed that K-reg and K-syn were the most influential factors of AChE activity at shorter and longer durations, respectively, after DFP challenge. Scale-up of the AChE dynamics from mouse to rat was also successful, as evidenced by significant overlapping between the predicted 95(th) percentile confidence intervals and the experimental data.
引用
收藏
页码:486 / 497
页数:12
相关论文
共 50 条
  • [1] Development of a Physiologically-Based Model for Diisopropylfluorophosphate-Induced Toxicity in Human
    Chen, K.
    Seng, K. Y.
    6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3, 2010, 31 : 1603 - 1606
  • [2] PHYSIOLOGICALLY BASED PHARMACOKINETIC AND PHARMACODYNAMIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY DIISOPROPYLFLUOROPHOSPHATE
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 106 (02) : 295 - 310
  • [3] Linkage of Diisopropylfluorophosphate Exposure and Effects in Rats Using a Physiologically Based Pharmacokinetic and Pharmacodynamic Model
    Seng, K. Y.
    Teo, S.
    Chen, K.
    Tan, K. C.
    13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3, 2009, 23 (1-3): : 1659 - +
  • [4] APPLICATIONS OF SENSITIVITY ANALYSIS TO A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR CARBON-TETRACHLORIDE IN RATS
    EVANS, MV
    CRANK, WD
    YANG, HM
    SIMMONS, JE
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 128 (01) : 36 - 44
  • [5] PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF EFAVIRENZ DOSE REDUCTION USING A PHYSIOLOGICALLY-BASED DYNAMIC MODEL
    Siccardi, M.
    Almond, L.
    Schipani, A.
    Csajka, C.
    Marzolini, C.
    Edwards, D.
    Khoo, S.
    Owen, A.
    Back, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S104 - S104
  • [6] Increased diisopropylfluorophosphate-induced toxicity in μ-opioid receptor knockout mice
    Tien, LT
    Fan, LW
    Ma, TG
    Loh, HH
    Ho, IK
    JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (02) : 259 - 267
  • [7] A physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model for the insecticide dimethoate
    Reiss, Richard
    Loccisano, Anne
    Deines, Andrew
    Kim, Myoungwoo
    Nallani, Gopinath
    Chandrasekaran, Appavu
    Whatling, Paul
    XENOBIOTICA, 2023, 53 (05) : 382 - 395
  • [8] Automated framework for global sensitivity analysis for the GastroPlus™ physiologically-based pharmacokinetic model
    Scherholz, Megerle L.
    Wang, Zilong
    Forder, James
    Ierapetritou, Marianthi
    Androulakis, Ioannis
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S40 - S41
  • [10] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300